| 1 |
Kim M, Lee DH, Byeon SH, et al. Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion. Br J Ophthalmol 2015;99:1271-6. |
미소장 |
| 2 |
Salman AG. Combined dexamethasone intravitreal implant (Ozurdex) and macular grid laser versus combined intravitreal bevacizumab and macular grid laser in branch retinal vein occlusion with macular edema. J Egypt Ophthalmol Soc 2015;108:190-7. |
미소장 |
| 3 |
Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review  |
미소장 |
| 4 |
Jefferies P, Clemett R, Day T. An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions. Aust N Z J Ophthalmol 1993;21:213-7. |
미소장 |
| 5 |
Janssen MC, den Heijer M, Cruysberg JR, et al. Retinal vein occlusion:a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005;93:1021-6. |
미소장 |
| 6 |
Laine I, Lindholm JM, Ylinen P, Tuuminen R. Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema. Clin Ophthalmol 2017;11:2107-12. |
미소장 |
| 7 |
Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12-month Follow-Up and Prognostic Factors  |
미소장 |
| 8 |
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: The 24-Week Results of the VIBRANT Study  |
미소장 |
| 9 |
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion  |
미소장 |
| 10 |
Scott IU, Ip MS, VanVeldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-28. |
미소장 |
| 11 |
Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion  |
미소장 |
| 12 |
Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion: Twelve-Month Study Results  |
미소장 |
| 13 |
Kang SA, Kim JW, Kim CG, et al. Short-term outcome of intravitreal dexamethasone implant for macular edema secondary to branch retinal vein occlusion. J Korean Ophthalmol Soc 2015;56:39-46. |
미소장 |
| 14 |
Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion:12-month results of a prospective clinical trial. Br J Ophthalmol 2009;93:452-6. |
미소장 |
| 15 |
Noh GM, Lee JE, Nam KY, et al. Macular ischemia correlated with final visual outcome in retinal vein occlusion patients. J Korean Ophthalmol Soc 2014;55:1493-8. |
미소장 |
| 16 |
Chung EJ, Hong YT, Lee SC, et al. Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2008;246:1241-7. |
미소장 |
| 17 |
Lim HB, Kim MS, Jo YJ, Kim JY. Prediction of retinal ischemia in branch retinal vein occlusion: spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci 2015;56:6622-9. |
미소장 |
| 18 |
Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 2008;16:791-9. |
미소장 |
| 19 |
Comparison of Bevacizumab and Triamcinolone for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion in a Pair-Matched Analysis  |
미소장 |
| 20 |
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: The 24-Week Results of the VIBRANT Study  |
미소장 |
| 21 |
Prospective pilot study: efficacy of intravitreal dexamethasone and bevacizumab injections in the treatment of macular oedema associated with branch retinal vein occlusion.  |
미소장 |
| 22 |
Maturi RK, Chen V, Raghinaru D, et al. A 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusion. Clin Ophthalmol 2014;8:1057-64. |
미소장 |
| 23 |
Moon SY, Cho KH, Woo SJ, et al. Bevacizumab versus dexamethasone implant followed by bevacizumab for the treatment of macula edema associated with branch retinal vein occlusion. Korean J Ophthalmol 2018;32:29-37. |
미소장 |
| 24 |
Sakamoto A, Tsujikawa A, Ota M, et al. Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion. Clin Exp Ophthalmol 2009;37:208-16. |
미소장 |
| 25 |
Chen SD, Sundaram V, Lochhead J, Patel CK. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2006;141:876-83. |
미소장 |
| 26 |
Kim JN, Lee SJ, Wang DH. Intraocular pressure changes in patients with retinal vein occlusion treated with intravitreal dexamethasone implant insertion. J Korean Ophthalmol Soc 2018;59:519-26. |
미소장 |
| 27 |
Manousaridis K, Talks J. Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease? Br J Ophthalmol 2012;96:179-84. |
미소장 |